Fruit-Fly Mating May Produce A Game Of Evolutionary Leapfrog

Male and female fruit flies have a common interest in reproduction, but they're at odds on one key point: While every male wants his sperm to fertilize the female's eggs, the female wants only certain males to succeed.

A new study co-authored by a biologist at the University of California, Davis, suggests that the conflict provokes continual tit-for-tat changes in the flies' genes -- a male-female game of leapfrog that could have important evolutionary consequences.

In the study, which appears in the Jan. 8 issue of the journal Science, UC Davis professor emeritus Timothy Prout and two collaborators arranged 6,200 fruit-fly matings and charted the paternity of the 125,000 subsequent offspring. The results revealed a new factor controlling sperm success: The male's genes had to match in certain ways with the female's genes.

In theory, under those conditions, males with the most successful genetic makeups would soon evolve to dominate the population. The researchers suggest that to forestall that happening, females frequently change their genetic profiles to alter the males' competitive odds.

"This sort of interaction could be an important factor for maintaining variation among the successful males," says Prout. "There's a lot of scientific interest in these issues of sexual selection, which occur not just in many insects, but also in some birds and mammals."

Prout's co-authors are Andrew Clark, professor of biology, Pennsylvania State University, and David Begun, assistant professor of zoology, University of Texas at Austin.


Contact: Timothy Prout
University of California - Davis

Page: 1

Related biology news :

1. Mating molds provide new insights into speciation and human reproduction
2. Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin
3. Dyed In The Silkworm: Researchers Develop Novel Way To Produce Colored Silk
4. Bioreactor Grows Cells That Produce Possible Anti-Cancer Protein
5. Genetically-Altered Crops Can Produce Tough, Hard-To-Kill Weeds
6. IFT/NCFST Symposium To Address Safety Of Fresh Produce
7. Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis
8. 3-D Structure of Human Tumor-Suppressor Protein Produced
9. Newly Discovered Bacteria Produce Magnetic Material
10. Evolutionary Genomics meeting in Tucson
11. Evolutionary speed limit governs how quickly life bounces back after extinction

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... ... company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a ... its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in ...
(Date:8/21/2020)... , ... August 18, 2020 , ... ... cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has ... lead asset, SBI-101, for the treatment of severe COVID-19. Approval of this IND ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
Breaking Biology Technology:
Cached News: